<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26312664</article-id>
      <article-id pub-id-type="pmc">4540498</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20153490</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A case of malignant atrophic papulosis with cranial nerve and peripheral
nerve impairment<xref ref-type="fn" rid="fn01">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Fang</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Haibo</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Min</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yan</surname>
            <given-names>Wenliang</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sang</surname>
            <given-names>Hong</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label>Jinling Hospital, Medical School of Nanjing University -
Nanjing, China.</aff>
      <author-notes>
        <corresp id="c01">MAILING ADDRESS: Hong Sang, Zhongshan East Road, Nanjing City,
Jiangsu, China. E-mail: <email>sanghong@nju.edu.cn</email></corresp>
        <fn fn-type="conflict">
          <p>Conflict of Interest: None.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>May-Jun</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>May-Jun</season>
        <year>2015</year>
      </pub-date>
      <volume>90</volume>
      <issue>3 Suppl 1</issue>
      <fpage>19</fpage>
      <lpage>21</lpage>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>2</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>02</day>
          <month>4</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2015 by Anais Brasileiros de
Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Malignant atrophic papulosisis is a rare, multisystem obliterative vasculopathy of
unknown etiology, occasionally involving the cranial nerve. We describe the first
case of malignant atrophic papulosisis with cranial nerve and peripheral nerve
involvement in China. A 47-year-old woman presented to our hospital with atrophic
porcelain white papules over the trunk and extremities, numbness in the right calf,
vision decrease and impaired movement of the right eye. She was diagnosed with
malignant atrophic papulosisis, based on characteristic symptoms and histopathologic
examination. The patient was treated with dipyridamole and aspirin for 9 months, but
later died of gastrointestinal hemorrhage. We reviewed currently available case
reports on cranial nerve involvement in malignant atrophic papulosisis and emphasized
the importance of skin biopsy in diagnosing this disease.</p>
      </abstract>
      <kwd-group>
        <kwd>Cranial nerve injuries</kwd>
        <kwd>Malignant atrophic papulosis</kwd>
        <kwd>Peripheral nerve injuries</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Malignant atrophic papulosis (MAP) is a rare, multisystem obliterative vasculopathy of
unknown etiology, occasionally involving the cranial nerve. We present a MAP case in a
47-year-old woman with cranial nerve and peripheral nerve involvement.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 47-year-old woman presented to our clinic with a 6-year history of asymptomatic
erythematous papules over the trunk and extremities. The lesions first appeared on her
right leg and healed spontaneously, leaving an atrophic residual scar. Similar skin
lesions had been appearing gradually and spreading across the whole body surface in the
subsequent 5 years. At the age of 46, the patient experienced a 2-hour episode of visual
field constriction in the right eye. Two months later, her right calf was anesthetic and
she noticed a painless vision decrease and permanent visual field constriction in her
right eye, which prompted her to seek advice.</p>
      <p>Cutaneous examination revealed multiple, round and linear, atrophic porcelain white
papules of 5-10mm in diameter over the trunk and extremities, with some showing an
erythematous telangiectatic peripheral halo (<xref ref-type="fig" rid="f01">Figure
1A</xref>). Neurologic examination found hypesthesia and paresis in the right calf.
Cranial nerves examination showed that the abducent nerve and optic nerve were impaired,
resulting in weakened movement on the right side, visual deterioration, and visual field
constriction of the right eye (<xref ref-type="fig" rid="f01">Figure 1B</xref>). Tendon
reflexes were normal and Babinski signs were negative.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>A. Cutaneous examination revealed multiple round and linear atrophic porcelain
white papules of 5-10mm, with some showing an erythematous telangiectatic
peripheral halo. B. Cranial nerves examination found impaired movement on the
right side, visual deterioration, and visual fi eld constriction of the right
eye</p>
        </caption>
        <graphic xlink:href="abd-90-03-s1-0019-g01"/>
      </fig>
      <p>Histopathology revealed central epidermal atrophy, papillary dermal sclerosis, and
perivascular lymphocytic inflammatory cell infiltrates, in addition to vascular
thrombosis (<xref ref-type="fig" rid="f02">Figure 2</xref>).</p>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Skin biopsies revealed perivascular lymphohistiocytic infi ltration. Vascular
occlusion was also observed(HE&#xD7;400)</p>
        </caption>
        <graphic xlink:href="abd-90-03-s1-0019-g02"/>
      </fig>
      <p>Analytical assessments were normal, including blood cell count, urinalysis, serum
chemistry analysis, immunoglobulin profile, myocardial enzymes, CRP, ESR, RF and all
plasma autoantibodies. But the fecal occult blood test was positive. Visual evoked
potential showed the optic nerve was damaged. Ophthalmoscopic findings were normal.
Gastroscopy examination uncovered chronic, gastric and duodenal inflammation. Screening
colonoscopy demonstrated that the colon was congestive, puffy and erosive, with small,
shallow ulcers. Chest computed tomography was normal. No intracerebral damage or venous
thrombosis was found, as evidenced by brain magnetic resonance imaging and magnetic
resonance angiography. Electromyologram (EMG) showed right quadriceps femoris neurogenic
damage.</p>
      <p>A diagnosis of MAP was made and the patient was treated with dipyridamole (50mg twice a
day) and aspirin (100mg once a day) for 9 months, experiencing no symptoms, skin lesion
improvement and no deterioration. The patient was lost to follow-up after 10 months. We
later learned that she had died of gastrointestinal hemorrhage a year after presenting
to our clinic.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>MAP, also known as Degos disease, is a rare, multisystem obliterative vasculopathy of
unknown etiology, which frequently affects the skin, gastrointestinal tract and central
nervous system. Immunological dysfunction, hyper-coagulation, fibrinolytic disturbances,
genetic predisposition and viral or streptococcal infection, may be involved in the
pathogenesis of MAP.<sup><xref rid="r01" ref-type="bibr">1</xref>-<xref rid="r03" ref-type="bibr">3</xref></sup> Drawing on the dialogue 'Degos disease' between Noah
Scheinfeld and Stuart Brown, Warren classified MAP into: classical MAP with systemic
manifestations, further subclassified into autoimmune MAP, coagulopathy-associated MAP
or virally-induced MAP; and benign cutaneous MAP.<sup><xref rid="r04" ref-type="bibr">4</xref></sup></p>
      <p>Our case is remarkable because of three unusual features. Firstly, physical examination
revealed impaired function of cranial nerves, II and VI on the right side, which
respectively manifested vision decrease and impaired movement on the right side of the
right eye. Her skin lesions were neglected when she visited the department of neurology
and ophthalmology. We reviewed currently available case reports on cranial nerve
involvement in MAP; our patient was the world's fourth reported case (<xref ref-type="table" rid="t01">Chart 1</xref>).<sup><xref rid="r05" ref-type="bibr">5</xref>-<xref rid="r07" ref-type="bibr">7</xref></sup> In addition, some other
ophthalmic signs have been reported in MAP, including conjunctival atrophic plaques,
telangiectatic vessels, scleral thinning, blepharoptosis and optic atrophy. <sup><xref rid="r06" ref-type="bibr">6</xref>,<xref rid="r08" ref-type="bibr">8</xref></sup>
Secondly, she repeatedly felt numbness in her right calf. EMG showed right quadriceps
femoris neurogenic damage, which suggested the patient also had peripheral nerve
involvement. Thirdly, although the patient had no clinical symptoms indicating
gastrointestinal involvement, the fecal occult blood test was positive and colonoscopy
showed that the colon was scattered with superficial ulceration, both of which prompted
the diagnosis of intestinal involvement. In ancestral literatures, about 15% of MAP
patients enjoy good health with their lesions limited to the skin.<sup><xref rid="r09" ref-type="bibr">9</xref></sup> Once multisystemic disease has developed,
death occurs in approximately 50% of patients within one to two years. The most common
causes of death are sepsis from peritonitis, CNS bleeding, and pleural or pericardial.
<sup><xref rid="r04" ref-type="bibr">4</xref></sup></p>
      <table-wrap id="t01" orientation="portrait" position="float">
        <label>CHART 1</label>
        <caption>
          <p>Patients' information statistics for cranial nerve involvement in MAP</p>
        </caption>
        <table frame="box" rules="groups">
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1">Year reported</th>
              <th align="left" rowspan="1" colspan="1">Source</th>
              <th align="left" rowspan="1" colspan="1">Age</th>
              <th align="left" rowspan="1" colspan="1">Gender</th>
              <th align="left" rowspan="1" colspan="1">Period of disease progress before cranial nerve involved</th>
              <th align="left" rowspan="1" colspan="1">Cranial nerve involved</th>
              <th align="left" rowspan="1" colspan="1">Clinical Performances of cranial nerve involved</th>
              <th align="left" rowspan="1" colspan="1">Therapy</th>
              <th align="left" rowspan="1" colspan="1">Results</th>
              <th align="left" rowspan="1" colspan="1">References</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">2009</td>
              <td align="left" rowspan="1" colspan="1">Birmingham UK</td>
              <td align="left" rowspan="1" colspan="1">6M</td>
              <td align="left" rowspan="1" colspan="1">Male</td>
              <td align="left" rowspan="1" colspan="1">3 weeks</td>
              <td align="left" rowspan="1" colspan="1">Oculomotor nerve</td>
              <td align="left" rowspan="1" colspan="1">Disconjugate eye movements</td>
              <td align="left" rowspan="1" colspan="1">Analgesics and antiepileptics</td>
              <td align="left" rowspan="1" colspan="1">Died of multiple progressive cerebral infarctions</td>
              <td align="left" rowspan="1" colspan="1">5</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#xA0;</td>
              <td align="left" rowspan="1" colspan="1">&#xA0;</td>
              <td align="left" rowspan="1" colspan="1">&#xA0;</td>
              <td align="left" rowspan="1" colspan="1">&#xA0;</td>
              <td align="left" rowspan="1" colspan="1">&#xA0;</td>
              <td align="left" rowspan="1" colspan="1">Abducent nerve</td>
              <td align="left" rowspan="1" colspan="1">&#xA0;</td>
              <td align="left" rowspan="1" colspan="1">&#xA0;</td>
              <td align="left" rowspan="1" colspan="1">&#xA0;</td>
              <td align="left" rowspan="1" colspan="1">&#xA0;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">2006</td>
              <td align="left" rowspan="1" colspan="1">Japan</td>
              <td align="left" rowspan="1" colspan="1">58Y</td>
              <td align="left" rowspan="1" colspan="1">Female</td>
              <td align="left" rowspan="1" colspan="1">Initially</td>
              <td align="left" rowspan="1" colspan="1">Optic nerve</td>
              <td align="left" rowspan="1" colspan="1">Loss of vision in the left eye</td>
              <td align="left" rowspan="1" colspan="1">Antiplatelet and anticoagulant</td>
              <td align="left" rowspan="1" colspan="1">Died of septic shock</td>
              <td align="left" rowspan="1" colspan="1">6</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">1992</td>
              <td align="left" rowspan="1" colspan="1">Japan</td>
              <td align="left" rowspan="1" colspan="1">41Y</td>
              <td align="left" rowspan="1" colspan="1">Male</td>
              <td align="left" rowspan="1" colspan="1">3 years</td>
              <td align="left" rowspan="1" colspan="1">Facial nerve</td>
              <td align="left" rowspan="1" colspan="1">Facial hypesthesia</td>
              <td align="left" rowspan="1" colspan="1">Heparin, urokinase, ticlopidine, dipyridamole, and
prednisolone</td>
              <td align="left" rowspan="1" colspan="1">Died of intracranial hemorrhages</td>
              <td align="left" rowspan="1" colspan="1">7</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">2013</td>
              <td align="left" rowspan="1" colspan="1">x country</td>
              <td align="left" rowspan="1" colspan="1">47Y</td>
              <td align="left" rowspan="1" colspan="1">Female</td>
              <td align="left" rowspan="1" colspan="1">6 years</td>
              <td align="left" rowspan="1" colspan="1">Optic nerve and abducent nerve</td>
              <td align="left" rowspan="1" colspan="1">Impaired movement on the right side, visual deterioration, and
visual fi eld constriction of the right eye</td>
              <td align="left" rowspan="1" colspan="1">Dipyridamole, aspirin</td>
              <td align="left" rowspan="1" colspan="1">Died of gastrointestinal hemorrhage</td>
              <td align="left" rowspan="1" colspan="1">Present case</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>There is no specific therapy for MAP. Some cases respond well to antiplatelets
treatment. Darwich has reported a MAP case in which skin lesions improved significantly
after treatment with chloroquine, aspirin and prednisone.<sup><xref rid="r02" ref-type="bibr">2</xref></sup> Magro has investigated four MAP cases and found prominent
vascular C5b-9 in the skin, gastrointestinal tract and brain.<sup><xref rid="r10" ref-type="bibr">10</xref></sup> In all cases, they also found evidence of high
interferon-&#xA9; (IFN-&#xA9;) expression. They proposed that C5 or IFN-&#xA9; may
emerge as potential candidate targets.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p>Financial Support: None.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>How to cite this article:</bold> Liu F, Liu HB, Zhang M, Yan WL, Sang H. A case
of malignant atrophic papulosis with cranial nerve and peripheral nerve impairment.
An Bras Dermatol. 2015;90(3 Suppl 1):S19-21.</p>
      </fn>
      <fn fn-type="other" id="fn01">
        <label>*</label>
        <p>Work performed at the Jinling Hospital Nanjing City - Jiangsu, China.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hohwy</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>T&#xF8;ttrup</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Steiniche</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fogh</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>A fatal case of malignant atrophic papulosis (Degos' disease) in a man
with factor V Leinden mutation and lupus anticoagulant</article-title>
          <source>Acta Derm Venereol</source>
          <year>2006</year>
          <volume>86</volume>
          <fpage>245</fpage>
          <lpage>247</lpage>
          <pub-id pub-id-type="pmid">16710585</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Darwich</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Guilabert</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mascar&#xF3;</surname>
              <given-names>JM</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Malvehy</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Puig</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fernandez-Figueras</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dermoscopic description of a patient with thrombocythemia and factor V
Leiden mutation-associated Degos' disease</article-title>
          <source>Int J Dermatol</source>
          <year>2011</year>
          <volume>50</volume>
          <fpage>604</fpage>
          <lpage>606</lpage>
          <pub-id pub-id-type="pmid">21506980</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pati</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Muley</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Grill</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Coons</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Post-streptococcal vasculopathy with evolution to Degos'
disease</article-title>
          <source>J Neurol Sci</source>
          <year>2011</year>
          <volume>300</volume>
          <fpage>157</fpage>
          <lpage>159</lpage>
          <pub-id pub-id-type="pmid">21035145</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heymann</surname>
              <given-names>WR</given-names>
            </name>
          </person-group>
          <article-title>Degos disease: considerations for reclassification</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2009</year>
          <volume>61</volume>
          <fpage>505</fpage>
          <lpage>506</lpage>
          <pub-id pub-id-type="pmid">19700015</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moss</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wassmer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Debelle</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hackett</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Goodyear</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Malcomson</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Degos disease: a new simulator of non-accidental
injury</article-title>
          <source>Dev Med Child Neurol</source>
          <year>2009</year>
          <volume>51</volume>
          <fpage>647</fpage>
          <lpage>650</lpage>
          <pub-id pub-id-type="pmid">19549203</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsuura</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Makino</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fukushima</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Shibuya</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Higuchi</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Optic nerve and spinal cord manifestations of malignant atrophic
papulosis (Degos disease)</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>2006</year>
          <volume>77</volume>
          <fpage>260</fpage>
          <lpage>262</lpage>
          <pub-id pub-id-type="pmid">16421135</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aizawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Takase</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Inoue</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Murayama</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mannen</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>An autopsy case of Degos disease with neurological
symptoms--neuropathological observations and increased platelet
aggregation</article-title>
          <source>Rinsho Shinkeigaku</source>
          <year>1992</year>
          <volume>32</volume>
          <fpage>23</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="pmid">1628433</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guti&#xE9;rrez-Pascual</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hern&#xE1;ndez-Mart&#xED;n</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Colmenero</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Garc&#xED;a-Pe&#xF1;as</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>L&#xF3;pez-Pino</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Torrelo</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Malignant atrophic papulosis: a case report with severe visual and
neurological impairment</article-title>
          <source>Pediatr Dermatol</source>
          <year>2011</year>
          <volume>28</volume>
          <fpage>302</fpage>
          <lpage>305</lpage>
          <pub-id pub-id-type="pmid">21133995</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wilson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Walling</surname>
              <given-names>HW</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Benign cutaneous Degos disease in a 16-yearold girl</article-title>
          <source>Pediatr Dermatol</source>
          <year>2007</year>
          <volume>24</volume>
          <fpage>18</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="pmid">17300643</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Magro</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Poe</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Shapiro</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Nuovo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Crow</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Crow</surname>
              <given-names>YJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Degos disease: a C5b-9/interferon-alpha-mediated endotheliopathy
syndrome</article-title>
          <source>Am J Clin Pathol</source>
          <year>2011</year>
          <volume>135</volume>
          <fpage>599</fpage>
          <lpage>610</lpage>
          <pub-id pub-id-type="pmid">21411783</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
